Company News

P&G’s Deal with ChromaDex

What's the plan for firm's proprietary derivative of niacin?

Author Image

By: Christine Esposito

Editor-in-Chief

ChromaDex Corp., which makes proprietary health, wellness and nutritional ingredients, has entered into a joint development agreement with The Procter & Gamble Company in which it will provide P&G exclusivity to its new proprietary ingredient for use in P&G branded products.   ChromaDex’s portfolio includes Niagen nicotinamide riboside, billed as the first and only commercially available form of nicotinamide riboside (NR), a highly effective NAD+ booster and “no flush” form of vit...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters